Apo-2 ligand
    4.
    发明授权
    Apo-2 ligand 失效
    Apo-2配体抗体

    公开(公告)号:US6046048A

    公开(公告)日:2000-04-04

    申请号:US780496

    申请日:1997-01-08

    IPC分类号: C07K14/705 C07K16/28 C12N5/16

    摘要: A novel cytokine, designated Apo-2 ligand, which induces mammalian cell apoptosis is provided. The Apo-2 ligand is believed to be a member of the TNF cytokine family. Compositions including Apo-2 ligand chimeras, nucleic acid encoding Apo-2 ligand, and antibodies to Apo-2 ligand are also provided. Methods of using Apo-2 ligand to induce apoptosis and to treat pathological conditions such as cancer, are further provided.

    摘要翻译: 提供了诱导哺乳动物细胞凋亡的新型细胞因子,称为Apo-2配体。 Apo-2配体被认为是TNF细胞因子家族的成员。 还提供了包括Apo-2配体嵌合体,编码Apo-2配体的核酸和Apo-2配体的抗体的组合物。 进一步提供了使用Apo-2配体诱导细胞凋亡和治疗病理状况如癌症的方法。

    Antibodies to &agr;v&bgr;3 integrin
    9.
    发明授权
    Antibodies to &agr;v&bgr;3 integrin 失效
    抗体为alphavbeta3整合素

    公开(公告)号:US06359126B1

    公开(公告)日:2002-03-19

    申请号:US08874837

    申请日:1997-06-13

    IPC分类号: C07H2104

    摘要: The invention relates to monoclonal antibodies to the &agr;v&bgr;3 integrin receptor known to be expressed in large amounts on the surface of osteoclasts and accordingly, associated with bone resorption. The disclosed monoclonal antibodies recognize unique epitopes on &agr;v&bgr;3 and are useful in the treatment of conditions associated with excessive bone resorption and/or in the inhibition of tumor cell growth.

    摘要翻译: 本发明涉及已知在破骨细胞表面上大量表达的α受体α整联蛋白受体的单克隆抗体,因此与骨吸收有关。 所公开的单克隆抗体识别出在alphavbeta3上的独特表位,并且可用于治疗与过量骨吸收和/或抑制肿瘤细胞生长相关的病症。